Plus500 does not provide CFD services to residents of the United States. Visit our U.S. website at us.plus500.com.

Halozyme Therapeutics HALO

48.44 0.29%
High: 48.88 Low: 48.26

Halozyme Therapeutics Inc. A U.S. biotechnology company that develops novel oncology therapies. Yahoo! Finance

Traders' Sentiments

Info

Halozyme Therapeutics Inc. A U.S. biotechnology company that develops novel oncology therapies. Yahoo! Finance

Spread 0.36 Spread (%) 0.74%
Overnight funding - Buy -0.05892% Overnight funding - Sell -0.0288%
Initial margin 20.00% Maintenance margin 10.00%
Leverage 1:5 Expires daily No

Related Instruments

How do I trade Halozyme Therapeutics?

Start trading Halozyme Therapeutics in just 5 steps:
  1. Explore what shifts the Halozyme Therapeutics price
  2. Learn about Halozyme Therapeutics trading in the Trading Academy
  3. Open and verify your Plus500 account
  4. Develop your trading strategy
  5. Execute your first trade on Halozyme Therapeutics

Related News & Market Insights

Why Plus500?

Protected & secure

Your data is safe and your funds are kept in segregated bank accounts, in accordance with regulatory requirements.

Professional support

Get around-the-clock dedicated customer service in multiple languages.

Regulated

Plus500EE AS is authorised and regulated by the Estonian Financial Supervision and Resolution Authority (Licence no. 4.1-1/18).

Reliable

Plus500 Ltd is a FTSE 250 company listed on the London Stock Exchange’s Main Market for Listed Companies.
Need Help?
24/7 Support